Reading 2023 ESC ACS guidelines between the lines: Gaps in evidence in women.

This article explores the gaps in knowledge and evidence surrounding the management of acute coronary syndromes (ACS) in women, as outlined in the 2023 guidelines from the European Society of Cardiology (ESC). It emphasizes the importance of understanding the differences between male and female patients in terms of access to emergency care, treatment, risk factors, and underlying mechanisms of ACS. The article also discusses the role of intracoronary imaging, coronary function testing, patient education, and antithrombotic therapy in managing ACS. It concludes by highlighting the need for increased representation of female patients in clinical trials to inform optimal management strategies for women with ACS. The text also addresses the gaps in knowledge regarding antithrombotic therapy in women, particularly in the context of ACS and spontaneous coronary artery dissection (SCAD). It stresses the need for more research and clinical trials specifically focused on women, as they are often underrepresented in these studies. The article also emphasizes the importance of considering diverse socioeconomic backgrounds and addressing potential sex biases in the management of ACS. The overall goal is to ensure that women with ACS receive evidence-based care and that future guidelines are informed by sex-stratified analyses. [Extracted from the article]